We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2014-04709-1-4
Submission Type
Major variation
Decision
Approved